Startups
Acurion's OncoGaze™ technology delivers critical genomic insights at the biopsy stage, empowering oncologists to make precision therapy a reality for more patients.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 2, 2026 | Acurion Completes $4.3M Seed Round | SAN DIEGO, CA, Acurion announced the closing of its oversubscribed seed financing round, raising $4.3 million against a $4 million target. >> Click here for more funding data on Acurion >> To export Acurion funding data to PDF ... |
| Acurion | “Acurion's OncoGaze™ technology delivers critical genomic insights at the biopsy stage, empowering oncologists to make precision therapy a reality for more patients.” |
Reviews 0
FAQ about Acurion
What has the press written about Acurion?
Parsers VC has collected 3 articles mentioning Acurion, among them “Acurion Completes $4.3M Seed Round” (Apr 2, 2026) and “Acurion”.
Is Acurion still active?
Yes, Acurion is active; its latest activity on Parsers VC dates from Jun 3, 2026.